Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

TFT Halls & Rooms

Nov 06, 2013 11:00 AM - Nov 06, 2013 12:45 PM

TFT Building, 3-6-11 Ariake, , Koto-ku,, Tokyo, 135-8071 Japan

#6: Control Strategy for Drug Substance Based on ICH M7 and Q11

Speakers

Haruhiro  Okuda, PhD

Haruhiro Okuda, PhD

Deputy Director General, National Institute of Health Sciences, Japan

Dr. Haruhiro Okuda is Honorary Director General of National Institute of Health Sciences (NIHS). After obtaining Ph.D degree in medicinal chemistry from University of Tokyo, he joined the Pharmaceuticals and Medical Devices Evaluation Center, the predecessor of PMDA. From 2002 to 2020, he worked for NIHS, and served as Head of Division of Organic Chemistry, Head of Division of Drugs and Director-General of NIHS. He worked to harmonize regulation on quality of chemical drugs for over 10 years as a member of ICH. He also works to harmonize Pharmacopoeias of Japan, EU, and the USA as a PDG (Pharmacopoeia Discussion Group) member. He has now worked for Pharmaceutical and Medical Device Regulatory Science Society of Japan.

Yukio  Aso, PhD

Yukio Aso, PhD

, National Institute of Health Sciences, Japan

Kazunori  Takagi, PhD

Kazunori Takagi, PhD

Deputy Review Director, Office of Generic Drugs, Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.